Characterization of SHV-5 β-lactamase-producing Klebsiella pneumoniae in an intensive care unit;Caracterización de Klebsiella pneumoniae productora de la β-lactamasa SHV-5, en una unidad de cuidados intensivos

Salud Publica de Mexico

Volumn 46, Issue 6, 2004, Pages 524-528

  Andrade, Verónica ^a   Espinosa De Los Monteros, Luz Elena ^b   Jiménez, Verónica ^b   Cervantes, Carlos ^c   Silva, Jesús ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^c UNIVERSIDAD MICHOACANA DE SAN NICOLÁS DE HIDALGO   (Mexico)

Author keywords

Bacterial typing techniques; Electrophoresis, gel pulsed field; Klebsilella pneumonias; Mexico; Polymerase chain reaction; Random amplified polymorphic DNA technique

Indexed keywords

BETA LACTAMASE; DNA;

ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; CHILD; CLINICAL ARTICLE; DISEASE TRANSMISSION; HEALTH CARE PERSONNEL; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; ISOELECTRIC FOCUSING; KLEBSIELLA PNEUMONIAE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; RANDOM AMPLIFIED POLYMORPHIC DNA; SEROTYPE;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CHILD; CROSS INFECTION; DISEASE OUTBREAKS; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; HEALTH PERSONNEL; HUMANS; INTENSIVE CARE UNITS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MEXICO; POLYMERASE CHAIN REACTION;

EID: 11844266586     PISSN: 00363634     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. González-Vértiz A, Alcántar-Curiel D, Cuauhtli M, Daza C, Gayosso C, Solache G et al. Multiresistant extended-spectrum β-lactamase-producing Klebsiella pneumoniae causing an outbreak of nosocomial bloodstream infection. Infect Control Hosp Epidemiol 2001; 22:723-725.
2. Vernon MO, Trick WE, Welbel SF, Peterson BJ, Weinstein RA. Adherence with hand hygiene: Does number of sinks matter? Infect Control Hosp Epidemiol 2003; 24:224-225.
3. Jacoby G, Busch K. Aminoacid sequences for TEM, SHV and OXA extended spectrum and inhibitor resistant β-lactamasa. Lahey Clinic. Disponible en: http://www.lahey.org/Studies/?D=http://www.lahey.org/studies/webt.stm&C=404, last modified - 09/03/04.
4. Martínez G, Alpuche C, Anaya C, Alcántara D, Gayosso C, Daza C et al. Outbreak of nosocomial sepsis and pneumonia in a Newborn Intensive Care Unit by multiresistant extended-spectrum β-Lactamase-producing Klebsiella pneumoniae: High impact on mortality. Infect Control Hosp Epidemiol 2001; 22:725-728.
5. Silva J, Gatica R, Aguilar C, Becerra Z, Garza U, Velázquez M et al. Outbreak of infection with extended-spectrum-β-lactamase-producing Klebsiella pneumoniae in a Mexican hospital. J Clin Microbiol 2001; 39: 3193-3196.
6. Miranda G, Castro N, Leaños B, Valenzuela A, Garza-Ramos U, Rojas T et al. Clonal and horizontal dissemination of Klebsiella pneumoniae expressing SHV-5 extended-spectrum β-Lactamase in a Mexican pediatric hospital. J Clin Microbiol 2004; 42:30-35.
7. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. Approved standard M100-S12. Wayne (PA): National Committee for Clinical Laboratory Standards; 2002; 22:42-46.
8. Kieser T. Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli. Plasmid 1984; 12:10-36.
9. Miller J. Experiments in molecular genetics. Cold Spring Harbour (NY): Cold Spring Harbour Laboratory; 1992:82-85.
10. Edwards PR, Fife MA. Capsule types of Klebsiella. 1952; 91:92-104.
11. Eisen D, Russell EG, Tymms M, Roper EJ, Grayson ML, Turnidge J. Random amplified polymorphic DNA and plasmid analysis used in investigation of an outbreak of multiresistant Klebsiella pneumoniae. J Clin Microbiol 1995; 33:713-717.
12. Matthew G, Hedges R, Smith J. Types of β-lactamases determined by plasmid in gram-negative bacteria. J Bacteriol 1979; 138:657-662.
13. Silva J, Aguilar C. β-Lactamase bioassay: A simplified method to determine extended-spectrum β-lactamases (ESBL) in enterobacteria. Arch Med Res 1997; 28:285-287.
14. Kaufmann ME. Pulsed-field gel electrophoresis. Methods Mol Med 1998; 15:17-31.
15. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing. J Clin Microbiol 1995; 33:2233-2239.
16. Barthelemy M, Peduzzi J, Labia R. Complete amino acid sequence of p453-plasmid-mediated PIT-2 β-lactamase (SHV-I). J Biochem 1988; 251:73-79.
17. Mondino SS, Castro AC, Mondino PJ, Carvalho Mda G, Silva KM, Teixeira LM. Phenotypic and genotypic characterization of clinical and intestinal enterococci isolated from inpatients and outpatient: Two Brazilian hospitals. Microb Drug Resist 2003; 9:167-174.
18. Girou E, Azar J, Wolkenstein P, Cizeau F, Brun-Buisson C, Roujeau JC. Comparison of systematic versus selective screening for methicillin-resistant Staphylococcus aureus carriage in a high-risk dermatology ward. Infect Control Hosp Epidemiol 2000; 21:583-587.
19. Martínez JI, Baquero F. Interactions among strategies associated with bacterial infection: Pathogenicity, epidemicity, and antibiotic resistance. Clin Microbiol Rev 2002; 15:647-679.
20. Webber M, Piddock L. The importance of efflux pumps in bacterial antibiotic resistance. J Antimicrob Chemother 2003; 51:9-11.
21. Hernández RI, Gaitán MJ, Gaitán GE. Extrinsic contamination of intravenous infusates administered to hospitalized children in Mexico. J Pediatr Infect Dis 2000; 19:888-890.
22. Macias AE, Bruckner DA, Hindler JA. Parenteral infusions as culture media from a viewpoint of nosocomial bacteremia. Rev Invest Clin 2000; 52: 39-43.